Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,270,928
-$362,403 QoQ
Shares Held
59,156
-6.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#181
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $996,376,961 across 14 Drug Manufacturers - General names. NVS ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300,851 | $360,849,743 | |
| 2 | JNJ |
Johnson & Johnson
|
1,286,261 | $326,671,705 | |
| 3 | ABBV |
AbbVie Inc.
|
323,203 | $81,330,801 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,084,726 | $62,501,910 | |
| 5 | MRK |
Merck & Co., Inc.
|
391,031 | $50,247,482 | |
| 6 | AMGN |
Amgen Inc
|
104,523 | $37,849,868 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
199,749 | $25,236,288 | |
| 8 | PFE |
Pfizer Inc
|
793,315 | $19,103,024 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,270,928 | 59,156 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $9,633,331 | 63,066 | Shares | Defined | 2026-05-26 | |
| 2025-12-31 | $7,498,197 | 54,386 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,985,322 | 26,779 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,905,481 | 29,858 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,326,246 | 37,613 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,217,731 | 39,618 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,818,125 | 39,472 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,134,418 | 40,947 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,967,751 | 38,953 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,852,037 | 38,173 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,511,916 | 38,173 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,240,789 | 35,723 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,794,963 | 36,771 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $3,548,145 | 41,975 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,763,509 | 42,889 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,841,244 | 43,915 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $3,394,687 | 41,510 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,806,532 | 41,720 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,737,356 | 43,722 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $5,907,445 | 62,559 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,893,191 | 67,769 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,889,726 | 78,884 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,330,334 | 101,035 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||